Chief Counsel, Corporate Affairs, Intellectual Property, Pfizer
Eric Aaronson is currently Chief Counsel, Corporate Affairs, Intellectual Property for Pfizer Inc. with responsibility for advising the company’s Corporate Affairs department and leading the patent, patent enforcement, trademark and IP policy teams. Prior to this role, Eric was Chief Counsel for Pfizer’s Global Innovative Pharma group with responsibility for its innovative pharmaceutical business, and then Chief Counsel for Pfizer’s Essential Health Business Unit, focusing on Pfizer’s biosimilar and generic portfolios. Before joining Pfizer in 2000, Eric worked at Kaye Scholer, LLP. He is a graduate of New York University School of Law.
June 10 @ 1:00 pm - 2:30 pm EDT